当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析

华北制药

(600812)

  

流通市值:76.97亿  总市值:80.98亿
流通股本:16.31亿   总股本:17.16亿

华北制药(600812)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.50亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益626336.47万元,未分配利润-57853.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2150896.18万元,负债1524559.70万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入7,974,681,092.85,233,404,242.632,660,096,706.2210,499,947,065.67
营业总成本7,859,360,976.385,158,617,183.572,624,501,680.1710,311,939,566.28
营业利润120,992,425.0482,518,686.6736,450,940.95-567,633,665.63
利润总额127,084,369.4887,297,997.8738,795,019.53-565,074,477.16
净利润50,382,686.4242,803,558.026,546,123.55-678,781,570.96
其他综合收益1,609,162.751,696,264.67-1,237,291.395,905,496.34
综合收益总额51,991,849.1744,499,822.695,308,832.16-672,876,074.62
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计9,084,512,483.518,948,204,316.529,624,208,691.518,982,898,658.97
非流动资产合计12,424,449,282.1812,165,562,988.7712,195,707,368.6212,238,119,247.43
资产总计21,508,961,765.6921,113,767,305.2921,819,916,060.1321,221,017,906.4
流动负债合计11,051,380,529.7511,017,794,761.9412,378,136,288.6312,409,218,693.25
非流动负债合计4,194,216,515.023,840,478,967.773,207,103,231.872,583,423,125.59
负债合计15,245,597,044.7714,858,273,729.7115,585,239,520.514,992,641,818.84
归属于母公司股东权益合计5,330,346,036.195,328,626,505.695,305,299,999.215,300,125,328.88
股东权益合计6,263,364,720.926,255,493,575.586,234,676,539.636,228,376,087.56
负债和股东权益合计21,508,961,765.6921,113,767,305.2921,819,916,060.1321,221,017,906.4
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计6,642,956,178.564,208,784,646.042,055,067,700.8810,367,931,311.59
经营活动现金流出小计6,049,231,151.023,943,799,545.671,867,208,958.59,363,540,516.98
经营活动产生的现金流量净额593,725,027.54264,985,100.37187,858,742.381,004,390,794.61
投资活动现金流入小计1,280,419.69373,400230,00023,119,471.24
投资活动现金流出小计430,130,233.54257,476,251.86117,369,011.38551,584,158.44
投资活动产生的现金流量净额-428,849,813.85-257,102,851.86-117,139,011.38-528,464,687.2
筹资活动现金流入小计8,215,709,448.635,503,252,576.513,137,941,250.3611,536,946,825.4
筹资活动现金流出小计8,520,941,767.915,570,407,396.282,829,416,042.0716,015,551,153.52
筹资活动产生的现金流量净额-305,232,319.28-67,154,819.77308,525,208.29-4,478,604,328.12
汇率变动对现金及现金等价物的影响9,176,198.467,511,289.22-1,270,066.78,438,239.4
现金及现金等价物净增加额-131,180,907.13-51,761,282.04377,974,872.59-3,994,239,981.31
期末现金及现金等价物余额923,387,147.151,002,806,772.241,432,542,926.871,054,568,054.28
TOP↑